Erratum: The high prevalence of infections and allergic symptoms in patients with ankylosing spondylitis is associated with clinical symptoms (Clinical Rheumatology 10.1007/s10067-005-0130-0);The high prevalence of infections and allergic symptoms in patients with ankylosing spondylitis is associated with clinical symptoms

Clinical Rheumatology

Volumn 25, Issue 5, 2006, Pages 648-658

  Zochling, Jane ^a   Bohl Bühler, Martin H J ^b   Baraliakos, Xenofon ^a   Feldtkeller, Ernst ^c   Braun, Jürgen ^a  

^a RHEUMAZENTRUM RUHRGEBIET   (Germany)

^b KB Practice for Internal Medicine   (Germany)

^c Ankylosing Spondylitis International Federation   (Germany)

Author keywords

Allergy; Ankylosing spondylitis; Infection

Indexed keywords

HLA B27 ANTIGEN; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ALLERGY; ANKYLOSING SPONDYLITIS; ARTHRITIS; ARTICLE; CLINICAL FEATURE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; ENTERITIS; FEMALE; GASTROINTESTINAL INFECTION; GENDER; HUMAN; INFECTION; INFORMATION PROCESSING; INTERVERTEBRAL DISK HERNIA; MAJOR CLINICAL STUDY; MALE; PAIN; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RESPIRATORY TRACT INFECTION; SUPERINFECTION; SYMPTOMATOLOGY; URINARY TRACT INFECTION;

EID: 33746368714     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-006-0333-z     Document Type: Erratum

References (45)

1. Wigley RD, Zhang NZ, Zeng QY, Shi CS, Hu DW, Couchman K et al (1994) Rheumatic diseases in China: ILAR-China study comparing the prevalence of rheumatic symptoms in northern and southern rural populations. J Rheumatol 21(8):1484-1490
2. Gofton JP, Robinson HS, Trueman GE (1966) Ankylosing spondylitis in a Canadian Indian population. Ann Rheum Dis 25(6):525-527
3. Braun J, Bollow M, Remlinger G, Eggens U, Rudwaleit M, Distler A et al (1998) Prevalence of spondyloarthropathies in HLA-B27 positive and negative blood donors. Arthritis Rheum 41(1):58-67
4. Brewerton DA, Hart FD, Nicholls A, Caffrey M, James DC, Sturrock RD (1973) Ankylosing spondylitis and HL-A 27. Lancet 1(7809):904-907
5. Schlosstein L, Terasaki PI, Bluestone R, Pearson CM (1973) High association of an HL-A antigen, W27, with ankylosing spondylitis. N Engl J Med 288(14):704-706
6. Sieper J, Braun J (1995) Pathogenesis of spondyloarthropathies. Persistent bacterial antigen, autoimmunity, or both? Arthritis Rheum 38(11):1547-1554
7. Maksymowych WP (2003) Etiology and pathogenesis of ankylosing spondylitis. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH (eds) Rheumatology. Elsevier, London, pp 1183-1192
8. Kapasi K, Inman RD (1992) HLA-B27 expression modulates gram-negative bacterial invasion into transfected L cells. J Immunol 148(11):3554-3559
9. Kapasi K, Inman RD (1994) ME1 epitope of HLA-B27 confers class I-mediated modulation of gram-negative bacterial invasion. J Immunol 153(2):833-840
10. Laitio P, Virtala M, Salmi M, Pelliniemi LJ, Yu DT, Granfors K (1997) HLA-B27 modulates intracellular survival of Salmonella enteritidis in human monocytic cells. Eur J Immunol 27(6):1331-1338
11. Rudwaleit M, Siegert S, Yin Z, Eick J, Thiel A, Radbruch A et al (2000) Low T cell production of TNFalpha and IFNgamma in ankylosing spondylitis: Its relation to HLA-B27 and influence of the TNF-308 gene polymorphism. Ann Rheum Dis 60(1):36-42
12. Granfors K, Märker-Hermann E, De Keyser F, Khan MA, Veys EM, Yu DTY (2002) The cutting edge of spondyloarthropathy research in the millennium. Arthritis Rheum 46(3):606-613
13. Monteleone G, Monteleone I, Fina D, Vavassori P, Del Vecchio BG, Caruso R et al (2005) Interleukin-21 enhances T-helper cell type I signaling and interferon-gamma production in Crohn's disease. Gastroenterology 128(3):687-694
14. Szegedi A, Aleksza M, Gonda A, Irinyi B, Sipka S, Hunyadi J et al (2003) Elevated rate of Thelper1 (T(H)1) lymphocytes and serum IFN-gamma levels in psoriatic patients. Immunol Lett 86(3):277-280
15. Jacob SE, Nassiri M, Kerdel FA, Vincek V (2003) Simultaneous measurement of multiple Th1 and Th2 serum cytokines in psoriasis and correlation with disease severity. Mediators Inflamm 12(5):309-313
16. Höhler T, Hug R, Schneider PM, Krummenauer F, Gripenberg-Lerche C, Granfors K et al (1999) Ankylosing spondylitis in monozygotic twins: studies on immunological parameters. Ann Rheum Dis 58(7):435-440
17. Rudwaleit M, Andermann B, Alten R, Sorensen H, Listing J, Zink A et al (2002) Atopic disorders in ankylosing spondylitis and rheumatoid arthritis. Ann Rheum Dis 61(11):968-974
18. Rose GA, Blackburn H (1968) Cardiovascular survey methods. WHO Report. World Health Organization, Geneva
19. Feldtkeller E, Khan MA, van der HD, van der LS, Braun J (2003) Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. Rheumatol Int 23(2):61-66
20. Feldtkeller E (1999) Erkrankungsalter und Diagnoseverzögerung bei Spondyloarthropathien. Z Rheumatol 58:21-30
21. Feldtkeller E, Lemmel EM (1999) Zur Situation von Spondyloarthritis-Patienten. Ergebnisse einer Repräsentativbefragung der Deutschen Vereinigung Murbus Bechterew. Novartis Pharma, Nuremberg
22. Feldtkeller E, Bruckel J, Khan MA (2000) Scientific contributions of ankylosing spondylitis patient advocacy groups. Curr Opin Rheumatol 12:239-247
23. Martinez A, Pacheco-Tena C, Vazquez-Mellado J, Burgos-Vargas R (2004) Relationship between disease activity and infection in patients with spondyloarthropathies. Ann Rheum Dis 63(10):1338-1340
24. Breustedt W, Giesel A, Puhlmann B (1989) Serum IgG antibodies to Chlamydia trachomatis in HLA-B-27 positive patients with rheumatic diseases. Dermatol Monatsschr 175(8):474-478
25. Gross WL, Ludemann G, Ullmann U, Schmidt KL (1983) Klebsiella-induced LIF response in Klebsiella infection and ankylosing spondylitis. Rheumatology 22(4):50-52
26. Hermann E, Sucké B, Droste U, Meyer zum Büschenfelde KH (1995) Klebsiella pneumoniae-reactive T cells in blood and synovial fluid of patients with ankylosing spondylitis. Comparison with HLA-B27+ healthy control subjects in a limiting dilution study and determination of the specificity of synovial fluid T cell clones. Arthritis Rheum 38(9):1277-1282
27. Ahmadi K, Wilson C, Tiwana H, Binder A, Ebringer A (1998) Antibodies to Klebsiella pneumoniae lipopolysaccharide in patients with ankylosing spondylitis. Rheumatology 37(12):1330-1333
28. Tani Y, Sato H, Tanaka N, Hukuda S (1997) Antibodies against bacterial lipopolysaccharides in Japanese patients with ankylosing spondylitis. Rheumatology 36(4):491-493
29. Tani Y, Tiwana H, Hukuda S, Nishioka J, Fielder M, Wilson C et al (1997) Antibodies to Klebsiella, Proteus, and HLA-B27 peptides in Japanese patients with ankylosing spondylitis and rheumatoid arthritis. J Rheumatol 24(1):109-114
30. Maki-Ikola O, Nissila M, Lehtinen K, Leirisalo-Repo M, Toivanen P, Granfors K (1995) Antibodies to Klebsiella pneumoniae, Escherichia coli and Proteus mirabilis in the sera of patients with axial and peripheral form of ankylosing spondylitis. Rheumatology 34(5):413-417
31. Maki-Ikola O, Lehtinen K, Granfors K, Vainionpää R, Toivanen P (1991) Bacterial antibodies in ankylosing spondylitis. Clin Exp Immunol 84(3):472-475
32. Chou CT, Uksila J, Toivanen P (1998) Enterobacterial antibodies in Chinese patients with rheumatoid arthritis and ankylosing spondylitis. Clin Exp Rheumatol 16(2):161-164
33. Sprenkels SH, van Kregten E, Feltkamp TE (1996) IgA antibodies against Klebsiella and other Gram-negative bacteria in ankylosing spondylitis and acute anterior uveitis. Clin Rheumatol 15(Suppl 1):48-51
34. Toivanen P, Koskimies S, Granfors K, Eerola E (1993) Bacterial antibodies in HLA-B27+ healthy individuals. Arthritis Rheum 36(11):1633-1635
35. Vaile JH, Meddings JB, Yacyshyn BR, Russell AS, Maksymowych WP (1999) Bowel permeability and CD45RO expression on circulating CD20+ B cells in patients with ankylosing spondylitis and their relatives. J Rheumatol 26(1):128-135
36. Mielants H, Veys EM, Goemaere S, Goethals K, Cuvelier C, De Vos M (1991) Gut inflammation in the spondyloarthropathies: Clinical, radiologic, biologic and genetic features in relation to the type of histology. A prospective study. J Rheumatol 18(10):1542-1551
37. Vorland LH, Carlson K, Aalen O (1985) An epidemiological survey of urinary tract infections among outpatients in Northern Norway. Scand J Infect Dis 17(3):277-283
38. Arpi M, Renneberg J, Andersen HK, Nielsen B, Larsen SO (1995) Bacteremia at a Danish university hospital during a twenty-five-year period (1968-1992). Scand J Infect Dis 27(3):245-251
39. Bignardi GE (1998) Risk factors for Clostridium difficile infection. J Hosp Infect 40(1):1-15
40. Loeb M (2003) Pneumonia in elderly persons. Clin Infect Dis 37(10):1335-1339
41. Leionen M (1993) Pathogenetic mechanisms and epidemiology of Chlamydia pneumoniae. Eur Heart J 14(Suppl K):57-61
42. Dougados M, Dijkmans B, Khan M, Maksymowych W, van der LS, Brandt J (2002) Conventional treatments for ankylosing spondylitis. Ann Rheum Dis 61(Suppl 3):iIi40-iii50
43. van der Horst-Bruinsma IE, Clegg DO, Dijkmans BA (2002) Treatment of ankylosing spondylitis with disease modifying antirheumatic drugs. Clin Exp Rheumatol 20(6 Suppl 28):S67-S70
44. Braun J, Sieper J (2004) Biological therapies in the spondyloarthritides - the current state. Rheumatology 43(9):1072-1084
45. Baeten D, Kruithof E, Van Den BF, Van den BN, Herssens A, Mielants H et al (2003) Systematic safety follow up in a cohort of 107 patients with spondyloarthropathy treated with infliximab: A new perspective on the role of host defence in the pathogenesis of the disease? Ann Rheum Dis 62(9):829-834